TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4713216
log Bayes Factor = 50.0079
Chromosome 6   position 29,364,147  (GRCh37) Explore rs4713216 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
1.000 0.000 0.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.001 0.999
E20-E35 Disorders of other endocrine glands
0.000 0.001 0.999
E10.3 With ophthalmic complications
0.000 0.001 0.999
E05.9 Thyrotoxicosis, unspecified
0.000 0.002 0.998
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.004 0.996
E27 Other disorders of adrenal gland
0.000 0.007 0.993
E10.2 With renal complications
0.000 0.011 0.989
E27.1 Primary adrenocortical insufficiency
0.000 0.017 0.983
E14 Unspecified diabetes mellitus
0.000 0.047 0.953
E13 Other specified diabetes mellitus
0.000 0.047 0.953
E24 Cushing's syndrome
0.000 0.050 0.950
E10.4 With neurological complications
0.000 0.066 0.934
E10.1 With ketoacidosis
0.000 0.074 0.926
E13.9 Without complications
0.000 0.081 0.919
E50-E64 Other nutritional deficiencies
0.000 0.086 0.914
E23 Hypofunction and other disorders of pituitary gland
0.000 0.094 0.906
E14.3 With ophthalmic complications
0.000 0.098 0.902
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.104 0.896
E20 Hypoparathyroidism
0.000 0.109 0.891
L40.9 Psoriasis, unspecified
0.878 0.122 0.000
E24.0 Pituitary-dependent Cushing's disease
0.000 0.143 0.857
E23.0 Hypopituitarism
0.000 0.161 0.839
E24.9 Cushing's syndrome, unspecified
0.000 0.173 0.827
E05.8 Other thyrotoxicosis
0.000 0.178 0.822
E55 Vitamin D deficiency
0.000 0.178 0.822
E20.9 Hypoparathyroidism, unspecified
0.000 0.186 0.814
E29 Testicular dysfunction
0.000 0.195 0.805
E14.6 With other specified complications
0.000 0.203 0.797
E53 Deficiency of other B group vitamins
0.000 0.207 0.793
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.208 0.792
E10.0 With coma
0.000 0.217 0.783
E22 Hyperfunction of pituitary gland
0.000 0.224 0.776
E53.9 Vitamin B deficiency, unspecified
0.000 0.238 0.762
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.240 0.760
E55.9 Vitamin D deficiency, unspecified
0.000 0.244 0.756
E51 Thiamine deficiency
0.000 0.245 0.755
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.248 0.751
E03 Other hypothyroidism
0.000 0.249 0.751
E10.7 With multiple complications
0.000 0.254 0.746
E23.2 Diabetes insipidus
0.000 0.256 0.744
E14.2 Withrenal complications
0.000 0.257 0.743
E24.2 Drug-induced Cushing's syndrome
0.000 0.268 0.732
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.716
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.716
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.284 0.716
E32 Diseases of thymus
0.000 0.284 0.716
E30 Disorders of puberty, not elsewhere classified
0.000 0.284 0.716
E27.5 Adrenomedullary hyperfunction
0.000 0.288 0.712
E27.0 Other adrenocortical overactivity
0.000 0.288 0.712
E40-E46 Malnutrition
0.000 0.289 0.711
L40 Psoriasis
0.706 0.294 0.000
E14.5 With peripheral circulatory complications
0.000 0.294 0.706
E25 Adrenogenital disorders
0.000 0.298 0.701
E27.8 Other specified disorders of adrenal gland
0.000 0.301 0.699
E10.8 With unspecified complications
0.000 0.312 0.688
E06 Thyroiditis
0.000 0.313 0.687
E10.6 With other specified complications
0.000 0.313 0.687
E14.8 With unspecified complications
0.000 0.313 0.687
E14.7 With multiple complications
0.000 0.317 0.683
E14.0 With coma
0.000 0.317 0.683
E13.8 With unspecified complications
0.000 0.317 0.683
E13.7 With multiple complications
0.000 0.317 0.683
E13.6 With other specified complications
0.000 0.317 0.683
E13.5 With peripheral circulatory complications
0.000 0.317 0.683
E13.4 With neurological complications
0.000 0.317 0.683
E13.2 With renal complications
0.000 0.317 0.683
E13.1 With ketoacidosis
0.000 0.317 0.683
E13.0 With coma
0.000 0.317 0.683
E31 Polyglandular dysfunction
0.000 0.318 0.681
E24.8 Other Cushing's syndrome
0.000 0.319 0.681
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.319 0.681
E24.3 Ectopic ACTH syndrome
0.000 0.319 0.681
E24.1 Nelson's syndrome
0.000 0.319 0.681
E13.3 With ophthalmic complications
0.000 0.319 0.681
E14.1 With ketoacidosis
0.000 0.335 0.665
E29.1 Testicular hypofunction
0.000 0.335 0.665
E28 Ovarian dysfunction
0.000 0.336 0.664
E27.9 Disorder of adrenal gland, unspecified
0.000 0.336 0.664
E61 Deficiency of other nutrient elements
0.000 0.342 0.658
E22.0 Acromegaly and pituitary gigantism
0.000 0.342 0.658
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.344 0.655
E50 Vitamin A deficiency
0.000 0.344 0.655
E60 Dietary zinc deficiency
0.000 0.344 0.655
E59 Dietary selenium deficiency
0.000 0.344 0.655
E52 Niacin deficiency [pellagra]
0.000 0.344 0.655
E10.5 With peripheral circulatory complications
0.000 0.346 0.654
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.350 0.649
E23.1 Drug-induced hypopituitarism
0.000 0.350 0.649
K90 Intestinal malabsorption
0.000 0.354 0.646
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.356 0.644
E51.2 Wernicke's encephalopathy
0.000 0.359 0.641
E20.8 Other hypoparathyroidism
0.000 0.361 0.639
E20.1 Pseudohypoparathyroidism
0.000 0.361 0.639
E20.0 Idiopathic hypoparathyroidism
0.000 0.361 0.639
E58 Dietary calcium deficiency
0.000 0.363 0.637
E14.4 With neurological complications
0.000 0.365 0.635
L40.5 Arthropathic psoriasis
0.625 0.375 0.000
E23.7 Disorder of pituitary gland, unspecified
0.000 0.375 0.625
E07 Other disorders of thyroid
0.000 0.384 0.616
E56 Other vitamin deficiencies
0.000 0.387 0.613
E14.9 Without complications
0.000 0.390 0.610
E26 Hyperaldosteronism
0.000 0.402 0.597
E22.1 Hyperprolactinaemia
0.000 0.407 0.593
E27.2 Addisonian crisis
0.000 0.411 0.589
E55.0 Rickets, active
0.000 0.411 0.589
E03.9 Hypothyroidism, unspecified
0.000 0.411 0.589
E16 Other disorders of pancreatic internal secretion
0.000 0.411 0.589
L40.8 Other psoriasis
0.587 0.413 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.420 0.580
L40.0 Psoriasis vulgaris
0.579 0.421 0.000
E29.9 Testicular dysfunction, unspecified
0.000 0.423 0.577
E29.8 Other testicular dysfunction
0.000 0.423 0.577
E29.0 Testicular hyperfunction
0.000 0.423 0.577
E53.1 Pyridoxine deficiency
0.000 0.431 0.569
E53.0 Riboflavin deficiency
0.000 0.431 0.569
E63 Other nutritional deficiencies
0.000 0.435 0.565
E54 Ascorbic acid deficiency
0.000 0.443 0.557
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.443 0.557
E22.8 Other hyperfunction of pituitary gland
0.000 0.443 0.557
E03.1 Congenital hypothyroidism without goitre
0.000 0.446 0.554
E34 Other endocrine disorders
0.000 0.449 0.551
E15 Nondiabetic hypoglycaemic coma
0.000 0.455 0.545
E51.9 Thiamine deficiency, unspecified
0.000 0.459 0.541
E51.8 Other manifestations of thiamine deficiency
0.000 0.459 0.541
E51.1 Beriberi
0.000 0.459 0.541
E03.5 Myxoedema coma
0.000 0.461 0.539
E03.4 Atrophy of thyroid (acquired)
0.000 0.461 0.539
E03.3 Postinfectious hypothyroidism
0.000 0.461 0.539
E23.6 Other disorders of pituitary gland
0.000 0.462 0.538
K90.9 Intestinal malabsorption, unspecified
0.000 0.467 0.533
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.469 0.531
E06.3 Autoimmune thyroiditis
0.000 0.478 0.522
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.483 0.517
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E30.9 Disorder of puberty, unspecified
0.000 0.486 0.514
E30.8 Other disorders of puberty
0.000 0.486 0.514
E30.1 Precocious puberty
0.000 0.486 0.514
E30.0 Delayed puberty
0.000 0.486 0.514
E32.9 Disease of thymus, unspecified
0.000 0.486 0.514
E32.8 Other diseases of thymus
0.000 0.486 0.514
E32.1 Abscess of thymus
0.000 0.486 0.514
E32.0 Persistent hyperplasia of thymus
0.000 0.486 0.514
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.486 0.514
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.486 0.514
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.486 0.514
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.490 0.510
E45 Retarded development following protein-energy malnutrition
0.000 0.490 0.510
E43 Unspecified severe protein-energy malnutrition
0.000 0.490 0.510
E42 Marasmic kwashiorkor
0.000 0.490 0.510
E41 Nutritional marasmus
0.000 0.490 0.510
E40 Kwashiorkor
0.000 0.490 0.510
E06.9 Thyroiditis, unspecified
0.000 0.492 0.508
L40.2 Acrodermatitis continua
0.506 0.493 0.000
E46 Unspecified protein-energy malnutrition
0.000 0.495 0.505
E25.9 Adrenogenital disorder, unspecified
0.000 0.497 0.503
E25.8 Other adrenogenital disorders
0.000 0.497 0.503
E61.2 Magnesium deficiency
0.000 0.498 0.502
E06.4 Drug-induced thyroiditis
0.000 0.507 0.493
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.507 0.493
E06.1 Subacute thyroiditis
0.000 0.507 0.493
E06.0 Acute thyroiditis
0.000 0.507 0.493
L40.3 Pustulosis palmaris et plantaris
0.492 0.508 0.000
E31.9 Polyglandular dysfunction, unspecified
0.000 0.511 0.489
E31.8 Other polyglandular dysfunction
0.000 0.511 0.489
E31.1 Polyglandular hyperfunction
0.000 0.511 0.489
L40.4 Guttate psoriasis
0.489 0.511 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.512 0.488
E16.1 Other hypoglycaemia
0.000 0.517 0.482
E28.2 Polycystic ovarian syndrome
0.000 0.519 0.481
L40.1 Generalised pustular psoriasis
0.479 0.521 0.000
E28.9 Ovarian dysfunction, unspecified
0.000 0.524 0.476
E28.8 Other ovarian dysfunction
0.000 0.524 0.476
E28.1 Androgen excess
0.000 0.524 0.476
E28.0 Oestrogen excess
0.000 0.524 0.476
E61.9 Deficiency of nutrient element, unspecified
0.000 0.528 0.472
E61.8 Deficiency of other specified nutrient elements
0.000 0.528 0.472
E61.7 Deficiency of multiple nutrient elements
0.000 0.528 0.472
E61.6 Vanadium deficiency
0.000 0.528 0.472
E61.5 Molybdenum deficiency
0.000 0.528 0.472
E61.4 Chromium deficiency
0.000 0.528 0.472
E61.3 Manganese deficiency
0.000 0.528 0.472
E61.0 Copper deficiency
0.000 0.528 0.472
E50.9 Vitamin A deficiency, unspecified
0.000 0.530 0.470
E50.8 Other manifestations of vitamin A deficiency
0.000 0.530 0.470
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.530 0.470
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.530 0.470
E50.5 Vitamin A deficiency with night blindness
0.000 0.530 0.470
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.530 0.470
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.530 0.470
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.530 0.470
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.530 0.470
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.530 0.470
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.530 0.470
E64.8 Sequelae of other nutritional deficiencies
0.000 0.530 0.470
E64.3 Sequelae of rickets
0.000 0.530 0.470
E64.2 Sequelae of vitamin C deficiency
0.000 0.530 0.470
E64.1 Sequelae of vitamin A deficiency
0.000 0.530 0.470
E64.0 Sequelae of protein-energy malnutrition
0.000 0.530 0.470
E03.8 Other specified hypothyroidism
0.000 0.532 0.468
K90.3 Pancreatic steatorrhoea
0.000 0.537 0.463
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.537 0.463
K90.1 Tropical sprue
0.000 0.537 0.463
E31.0 Autoimmune polyglandular failure
0.000 0.546 0.454
K90.8 Other intestinal malabsorption
0.000 0.552 0.447
E26.9 Hyperaldosteronism, unspecified
0.000 0.555 0.445
E07.1 Dyshormogenetic goitre
0.000 0.558 0.442
E07.0 Hypersecretion of calcitonin
0.000 0.558 0.442
E56.9 Vitamin deficiency, unspecified
0.000 0.560 0.439
E56.8 Deficiency of other vitamins
0.000 0.560 0.439
E56.0 Deficiency of vitamin E
0.000 0.560 0.439
E61.1 Iron deficiency
0.000 0.562 0.438
E26.8 Other hyperaldosteronism
0.000 0.571 0.428
E26.1 Secondary hyperaldosteronism
0.000 0.571 0.428
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.578 0.422
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.578 0.422
E16.4 Abnormal secretion of gastrin
0.000 0.578 0.422
E16.3 Increased secretion of glucagon
0.000 0.578 0.422
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.578 0.421
E07.8 Other specified disorders of thyroid
0.000 0.581 0.419
E28.3 Primary ovarian failure
0.000 0.583 0.417
E16.2 Hypoglycaemia, unspecified
0.000 0.586 0.414
E63.8 Other specified nutritional deficiencies
0.000 0.595 0.405
E63.1 Imbalance of constituents of food intake
0.000 0.595 0.405
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.595 0.405
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.595 0.405
E06.5 Other chronic thyroiditis
0.000 0.598 0.402
E34.3 Short stature, not elsewhere classified
0.000 0.599 0.401
E56.1 Deficiency of vitamin K
0.000 0.603 0.397
E34.5 Androgen resistance syndrome
0.000 0.605 0.395
E34.4 Constitutional tall stature
0.000 0.605 0.395
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.605 0.395
E34.1 Other hypersecretion of intestinal hormones
0.000 0.605 0.395
E07.9 Disorder of thyroid, unspecified
0.000 0.627 0.373
E44.1 Mild protein-energy malnutrition
0.000 0.634 0.366
E44.0 Moderate protein-energy malnutrition
0.000 0.634 0.366
E34.8 Other specified endocrine disorders
0.000 0.638 0.362
E34.9 Endocrine disorder, unspecified
0.000 0.640 0.360
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.645 0.354
E34.0 Carcinoid syndrome
0.000 0.674 0.325
E63.9 Nutritional deficiency, unspecified
0.001 0.685 0.315
E26.0 Primary hyperaldosteronism
0.001 0.721 0.279
E65-E68 Obesity and other hyperalimentation
0.000 0.734 0.265
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.798 0.202
E67 Other hyperalimentation
0.000 0.809 0.190
E68 Sequelae of hyperalimentation
0.000 0.809 0.190
E53.8 Deficiency of other specified B group vitamins
0.000 0.818 0.182
E21.4 Other specified disorders of parathyroid gland
0.000 0.855 0.145
E11 Non-insulin-dependent diabetes mellitus
0.000 0.861 0.139
E21.2 Other hyperparathyroidism
0.000 0.862 0.138
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.863 0.137
E67.8 Other specified hyperalimentation
0.000 0.863 0.137
E67.3 Hypervitaminosis D
0.000 0.863 0.137
E67.2 Megavitamin-B6 syndrome
0.000 0.863 0.137
E67.1 Hypercarotenaemia
0.000 0.863 0.137
E67.0 Hypervitaminosis A
0.000 0.863 0.137
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.874 0.125
E11.9 Without complications
0.000 0.875 0.125
E11.6 With other specified complications
0.000 0.892 0.108
M35.0 Sicca syndrome [Sjogren]
0.000 0.892 0.108
E04 Other non-toxic goitre
0.002 0.894 0.105
L40-L45 Papulosquamous disorders
0.103 0.896 0.001
E65 Localised adiposity
0.001 0.896 0.103
E11.2 With renal complications
0.000 0.897 0.103
E11.7 With multiple complications
0.000 0.900 0.100
E11.8 With unspecified complications
0.000 0.904 0.096
E11.0 With coma
0.000 0.918 0.082
E21.3 Hyperparathyroidism, unspecified
0.000 0.918 0.082
E04.9 Non-toxic goitre, unspecified
0.000 0.924 0.076
E04.8 Other specified non-toxic goitre
0.001 0.924 0.075
L44 Other papulosquamous disorders
0.074 0.925 0.001
L41 Parapsoriasis
0.074 0.925 0.001
L45 Papulosquamous disorders in diseases classified elsewhere
0.074 0.925 0.001
E11.1 With ketoacidosis
0.000 0.937 0.063
E83 Disorders of mineral metabolism
0.061 0.939 0.001
L42 Pityriasis rosea
0.054 0.946 0.001
L41.9 Parapsoriasis, unspecified
0.053 0.946 0.001
L41.8 Other parapsoriasis
0.053 0.946 0.001
L41.5 Retiform parapsoriasis
0.053 0.946 0.001
L41.4 Large plaque parapsoriasis
0.053 0.946 0.001
L41.3 Small plaque parapsoriasis
0.053 0.946 0.001
L41.2 Lymphomatoid papulosis
0.053 0.946 0.001
L41.1 Pityriasis lichenoides chronica
0.053 0.946 0.001
L41.0 Pityriasis lichenoides et varioliformis acuta
0.053 0.946 0.001
L44.9 Papulosquamous disorder, unspecified
0.053 0.946 0.001
L44.8 Other specified papulosquamous disorders
0.053 0.946 0.001
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.053 0.946 0.001
L44.3 Lichen ruber moniliformis
0.053 0.946 0.001
L44.2 Lichen striatus
0.053 0.946 0.001
L44.1 Lichen nitidus
0.053 0.946 0.001
L44.0 Pityriasis rubra pilaris
0.053 0.946 0.001
E11.5 With peripheral circulatory complications
0.000 0.954 0.046
E04.0 Non-toxic diffuse goitre
0.002 0.955 0.044
E83.8 Other disorders of mineral metabolism
0.044 0.956 0.001
E83.2 Disorders of zinc metabolism
0.044 0.956 0.001
E83.0 Disorders of copper metabolism
0.044 0.956 0.001
E83.9 Disorder of mineral metabolism, unspecified
0.043 0.956 0.001
E21.0 Primary hyperparathyroidism
0.000 0.959 0.041
K90-K93 Other diseases of the digestive system
0.000 0.960 0.040
E83.3 Disorders of phosphorus metabolism
0.037 0.963 0.000
L43 Lichen planus
0.031 0.968 0.002
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.971 0.029
E11.4 With neurological complications
0.000 0.973 0.027
L43.3 Subacute (active) lichen planus
0.022 0.977 0.001
L43.2 Lichenoid drug reaction
0.022 0.977 0.001
L43.1 Bullous lichen planus
0.022 0.977 0.001
L43.0 Hypertrophic lichen planus
0.022 0.977 0.001
T84.1 Mechanical complication of internal fixation device of bones of limb
0.000 0.977 0.023
E11.3 With ophthalmic complications
0.000 0.978 0.022
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.979 0.021
K93.1 Megacolon in Chagas' disease
0.000 0.979 0.021
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.979 0.021
E66 Obesity
0.000 0.979 0.021
M35 Other systemic involvement of connective tissue
0.000 0.983 0.017
L43.8 Other lichen planus
0.015 0.983 0.002
E83.4 Disorders of magnesium metabolism
0.016 0.984 0.000
E66.1 Drug-induced obesity
0.000 0.985 0.015
C50.3 Lower-inner quadrant of breast
0.000 0.985 0.015
E66.0 Obesity due to excess calories
0.000 0.987 0.013
M35.8 Other specified systemic involvement of connective tissue
0.000 0.988 0.012
M35.9 Systemic involvement of connective tissue, unspecified
0.000 0.988 0.012
M35.6 Relapsing panniculitis [Weber-Christian]
0.000 0.988 0.012
M35.5 Multifocal fibrosclerosis
0.000 0.988 0.012
M35.4 Diffuse (eosinophilic) fasciitis
0.000 0.988 0.012
M35.1 Other overlap syndromes
0.000 0.988 0.011
M35.2 Behcet's disease
0.000 0.988 0.011
B97.8 Other viral agents as the cause of diseases classified to other chapters
0.011 0.989 0.000
M35.7 Hypermobility syndrome
0.000 0.990 0.010
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.991 0.009
E04.2 Non-toxic multinodular goitre
0.001 0.991 0.008
M35.99 Systemic involvement of connective tissue, unspecified, Site unspecified
0.000 0.991 0.009
H90 Conductive and sensorineural hearing loss
0.000 0.991 0.009
L27.0 Generalised skin eruption due to drugs and medicaments
0.000 0.991 0.009
H90.2 Conductive hearing loss, unspecified
0.000 0.991 0.009
E04.1 Non-toxic single thyroid nodule
0.003 0.991 0.006
H90.8 Mixed conductive and sensorineural hearing loss, unspecified
0.000 0.991 0.009
H90.3 Sensorineural hearing loss, bilateral
0.000 0.991 0.009
E83.5 Disorders of calcium metabolism
0.008 0.992 0.000
H90.5 Sensorineural hearing loss, unspecified
0.000 0.992 0.008
M22.2 Patellofemoral disorders
0.000 0.992 0.008
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.992 0.008
H90.6 Mixed conductive and sensorineural hearing loss, bilateral
0.000 0.992 0.008
H26.9 Cataract, unspecified
0.000 0.993 0.007
X41.9 Unspecified place
0.007 0.993 0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.994 0.006
B97 Viral agents as the cause of diseases classified to other chapters
0.006 0.994 0.000
M22 Disorders of patella
0.000 0.995 0.005
B97.7 Papillomavirus as the cause of diseases classified to other chapters
0.005 0.995 0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.995 0.005
H90.0 Conductive hearing loss, bilateral
0.000 0.995 0.005
M34.1 CR(E)ST syndrome
0.000 0.995 0.005
A08.4 Viral intestinal infection, unspecified
0.000 0.995 0.005
C50.1 Central portion of breast
0.000 0.995 0.005
M34 Systemic sclerosis
0.000 0.995 0.005
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.005 0.995 0.000
M34.9 Systemic sclerosis, unspecified
0.000 0.995 0.005
C50.8 Overlapping lesion of breast
0.000 0.996 0.004
M22.8 Other disorders of patella
0.000 0.996 0.004
L27 Dermatitis due to substances taken internally
0.000 0.996 0.004
B97.6 Parvovirus as the cause of diseases classified to other chapters
0.004 0.996 0.000
B97.5 Reovirus as the cause of diseases classified to other chapters
0.004 0.996 0.000
B97.3 Retrovirus as the cause of diseases classified to other chapters
0.004 0.996 0.000
B97.2 Coronavirus as the cause of diseases classified to other chapters
0.004 0.996 0.000
B97.0 Adenovirus as the cause of diseases classified to other chapters
0.004 0.996 0.000
M31.6 Other giant cell arteritis
0.000 0.996 0.004
M22.0 Recurrent dislocation of patella
0.000 0.996 0.004
C50 Malignant neoplasm of breast
0.000 0.996 0.004
M34.8 Other forms of systemic sclerosis
0.000 0.996 0.004
B97.4 Respiratory synctial virus as the cause of diseases classified to other chapters
0.004 0.996 0.000
M22.9 Disorder of patella, unspecified
0.000 0.996 0.004
A87.9 Viral meningitis, unspecified
0.000 0.996 0.004
L43.9 Lichen planus, unspecified
0.002 0.996 0.002
B97.1 Enterovirus as the cause of diseases classified to other chapters
0.004 0.996 0.000
M22.1 Recurrent subluxation of patella
0.000 0.996 0.004
N08.3 Glomerular disorders in diabetes mellitus
0.000 0.996 0.004
C50.0 Nipple and areola
0.000 0.996 0.004
M34.2 Systemic sclerosis induced by drugs and chemicals
0.000 0.996 0.004
L27.2 Dermatitis due to ingested food
0.000 0.996 0.003
M20-M25 Other joint disorders
0.000 0.996 0.004
X41.0 Home
0.003 0.996 0.000
X41.8 Other specified place
0.003 0.996 0.000
X41.7 Farm
0.003 0.996 0.000
X41.6 Industrial and construction area
0.003 0.996 0.000
X41.5 Trade and service area
0.003 0.996 0.000
X41.4 Street and highway
0.003 0.996 0.000
X41.3 Sports and athletics area
0.003 0.996 0.000
X41.2 School, other institution and public administrative area
0.003 0.996 0.000
X41.1 Residential institution
0.003 0.996 0.000
M34.0 Progressive systemic sclerosis
0.000 0.996 0.003
M32 Systemic lupus erythematosus
0.000 0.996 0.004
V18.0 Driver injured in nontraffic accident
0.004 0.996 0.000
E70-E90 Metabolic disorders
0.001 0.996 0.003
M22.3 Other derangements of patella
0.000 0.997 0.003
M31 Other necrotising vasculopathies
0.000 0.997 0.003
L27.9 Dermatitis due to unspecified substance taken internally
0.000 0.997 0.003
L27.8 Dermatitis due to other substances taken internally
0.000 0.997 0.003
H11.4 Other conjunctival vascular disorders and cysts
0.003 0.997 0.000
M35.3 Polymyalgia rheumatica
0.000 0.997 0.003
S82.10 Fracture of upper end of tibia (closed)
0.000 0.997 0.003
L27.1 Localised skin eruption due to drugs and medicaments
0.000 0.997 0.003
L53.9 Erythematous condition, unspecified
0.003 0.997 0.000
M32.1 Systemic lupus erythematosus with organ or system involvement
0.000 0.997 0.003
K92 Other diseases of digestive system
0.001 0.997 0.002
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.997 0.003
M32.8 Other forms of systemic lupus erythematosus
0.000 0.997 0.003
M22.10 Recurrent subluxation of patella, unspecified knee
0.000 0.997 0.003
D47.4 Osteomyelofibrosis
0.000 0.997 0.003
H26.1 Traumatic cataract
0.000 0.997 0.003
H26 Other cataract
0.000 0.997 0.003
V18 Pedal cyclist injured in noncollision transport accident
0.003 0.997 0.000
V17.4 Driver injured in traffic accident
0.003 0.997 0.000
H26.4 After-cataract
0.000 0.997 0.003
E73 Lactose intolerance
0.000 0.997 0.003
K62.4 Stenosis of anus and rectum
0.000 0.997 0.003
C77.4 Inguinal and lower limb lymph nodes
0.000 0.997 0.003
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.997 0.003
K51.4 Pseudopolyposis of colon
0.003 0.997 0.000
X41.08 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified , Home ,While engaged in other specified activities
0.003 0.997 0.000
E79 Disorders of purine and pyrimidine metabolism
0.001 0.997 0.002
M31.8 Other specified necrotising vasculopathies
0.000 0.997 0.003
M36 Systemic disorders of connective tissue in diseases classified elsewhere
0.000 0.997 0.003
B02.2 Zoster with other nervous system involvement
0.000 0.997 0.003
C50.6 Axillary tail of breast
0.000 0.997 0.003
N48.4 Impotence of organic origin
0.003 0.997 0.000
M32.9 Systemic lupus erythematosus, unspecified
0.000 0.997 0.003
M32.0 Drug-induced systemic lupus erythematosus
0.000 0.997 0.003
E70 Disorders of aromatic amino-acid metabolism
0.001 0.997 0.002
E77 Disorders of glycoprotein metabolism
0.001 0.997 0.002
E76 Disorders of glycosaminoglycan metabolism
0.001 0.997 0.002
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.001 0.997 0.002
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.001 0.997 0.002
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)
0.003 0.997 0.000
V18.1 Passenger injured in nontraffic accident
0.003 0.997 0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)
0.000 0.997 0.003
M31.7 Microscopic polyangiitis
0.000 0.997 0.003
M31.4 Aortic arch syndrome [Takayasu]
0.000 0.997 0.003
M31.2 Lethal midline granuloma
0.000 0.997 0.003
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.003 0.997 0.000
M30 Polyarteritis nodosa and related conditions
0.000 0.997 0.003
M31.1 Thrombotic microangiopathy
0.000 0.997 0.003
V18.5 Passenger injured in traffic accident
0.003 0.997 0.000
L08.8 Other specified local infections of skin and subcutaneous tissue
0.003 0.997 0.000
E84 Cystic fibrosis
0.001 0.997 0.002
V17 Pedal cyclist injured in collision with fixed or stationary object
0.003 0.997 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.003 0.997 0.000
E72 Other disorders of amino-acid metabolism
0.001 0.997 0.002
E73.9 Lactose intolerance, unspecified
0.000 0.997 0.002
M31.0 Hypersensitivity angiitis
0.000 0.997 0.003
E74 Other disorders of carbohydrate metabolism
0.001 0.997 0.002
K92.9 Disease of digestive system, unspecified
0.000 0.997 0.002
M31.9 Necrotising vasculopathy, unspecified
0.000 0.997 0.002
M31.5 Giant cell arteritis with polymyalgia rheumatica
0.000 0.997 0.003
F45.8 Other somatoform disorders
0.000 0.997 0.003
E85 Amyloidosis
0.000 0.997 0.002
H26.2 Complicated cataract
0.000 0.997 0.003
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.001 0.997 0.002
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.997 0.002
K91.1 Postgastric surgery syndromes
0.000 0.997 0.002
Z80.9 Family history of malignant neoplasm, unspecified
0.000 0.997 0.003
D47.3 Essential (haemorrhagic) thrombocythaemia
0.000 0.997 0.003
N08 Glomerular disorders in diseases classified elsewhere
0.000 0.997 0.002
V10-V19 Pedal cyclist injured in transport accident
0.002 0.997 0.000
S32.10 Fracture of sacrum (closed)
0.002 0.998 0.000
V18.9 Unspecified pedal cyclist injured in traffic accident
0.002 0.998 0.000
V18.4 Driver injured in traffic accident
0.002 0.998 0.000
A08 Viral and other specified intestinal infections
0.000 0.998 0.002
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.998 0.002
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
0.002 0.998 0.000
A08.3 Other viral enteritis
0.000 0.998 0.002
E66.8 Other obesity
0.000 0.998 0.002
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.998 0.002
H26.3 Drug-induced cataract
0.000 0.998 0.002
A87 Viral meningitis
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.